Table 3.
Significant SNPs from pancreatic injury GWAS analysis in BioVU cohort. Analysis is adjusted for 10 principal components of ancestry, sex, age at event, and indication
| CHR | POS | RSID | GENE | REF | ALT | MAF | OR | P |
|---|---|---|---|---|---|---|---|---|
| 1 | 23051264 | rs72653622 | EPHB2 | G | A | 0.02 | 8.59 | 1.84E‐08 |
| 5 | 25132974 | rs200407865 | LINC02228 | G | T | 0.01 | 12.60 | 9.76E‐09 |
| 7 | 140125750 | rs2948386 | RAB19 | T | C | 0.26 | 3.47 | 1.46E‐08 |
| 9 | 5525874 | rs147662134 |
CD274, PDCD1LG2, PLGRKT |
T | C | 0.06 | 4.80 | 2.49E‐08 |
| 18 | 41222682 | rs113528748 | NA | A | G | 0.01 | 10.67 | 1.67E‐08 |
| 18 | 41481974 | rs117940420 | LOC105372088 | T | G | 0.01 | 11.12 | 1.05E‐08 |
| 18 | 41619694 | rs142640276 | NA | C | G | 0.01 | 11.61 | 6.61E‐09 |
| 18 | 41710279 | rs191224981 | NA | T | C | 0.01 | 10.21 | 2.77E‐08 |